• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种靶向c-Met用于肝细胞癌诊断的新型肽。

A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis.

作者信息

Tang Yongjia, Xu Haoran, Dai Yaxue, Wang Fang, Huang Wenjing, Liu Peifei, Gu Yueqing

机构信息

State Key Laboratory of Natural Medicine, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, No. 24 Tongjia Lane, Gulou District, Nanjing 211198, China.

出版信息

J Mater Chem B. 2021 Jun 2;9(22):4577-4586. doi: 10.1039/d1tb00408e.

DOI:10.1039/d1tb00408e
PMID:34047746
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with limited diagnosis. Mesenchymal epithelial transition factor (c-Met) has become a hot target for cancer diagnosis and therapy, which is overexpressed in HCC. In this study, we labeled a novel c-Met targeting peptide YQ-M3 with a near-infrared fluorescent dye MPA and a radionuclide technetium-99m for HCC detection. YQ-M3-MPA showed high affinity for c-Met positive HepG2 tumor in vitro and higher tumor uptake and higher T/N ratio than GE137-MPA (a positive tracer for c-Met) in HepG2 tumor-bearing mice in vivo by fluorescence imaging. In addition, 99mTc-HYNIC-YQ-M3 also showed significant tumor uptake in vivo through SPECT imaging. These results indicated that c-Met positive tumors were successfully detected via fluorescence and SPECT imaging using YQ-M3-MPA and 99mTc-HYNIC-YQ-M3, respectively, and further suggested that YQ-M3-MPA and 99mTc-HYNIC-YQ-M3 have some possibly potential clinical applications for HCC diagnosis.

摘要

肝细胞癌(HCC)是诊断手段有限的最常见恶性肿瘤之一。间充质上皮转化因子(c-Met)已成为癌症诊断和治疗的热门靶点,其在HCC中过表达。在本研究中,我们用近红外荧光染料MPA和放射性核素锝-99m标记了一种新型的靶向c-Met肽YQ-M3用于HCC检测。YQ-M3-MPA在体外对c-Met阳性的HepG2肿瘤显示出高亲和力,并且通过荧光成像在体内荷HepG2肿瘤小鼠中比GE137-MPA(一种c-Met阳性示踪剂)具有更高的肿瘤摄取和更高的T/N比值。此外,99mTc-HYNIC-YQ-M3通过SPECT成像在体内也显示出显著的肿瘤摄取。这些结果表明,分别使用YQ-M3-MPA和99mTc-HYNIC-YQ-M3通过荧光和SPECT成像成功检测到了c-Met阳性肿瘤,并进一步表明YQ-M3-MPA和99mTc-HYNIC-YQ-M3在HCC诊断方面具有一些潜在的临床应用价值。

相似文献

1
A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis.一种靶向c-Met用于肝细胞癌诊断的新型肽。
J Mater Chem B. 2021 Jun 2;9(22):4577-4586. doi: 10.1039/d1tb00408e.
2
AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis.AT1R特异性配体血管紧张素II作为一种新型的用于肝细胞癌诊断的单光子发射计算机断层显像剂。
ACS Sens. 2020 Dec 24;5(12):4072-4080. doi: 10.1021/acssensors.0c02180. Epub 2020 Nov 24.
3
Multi-modal imaging probe for EpCAM overexpressed in breast cancer.用于检测乳腺癌中过表达的上皮细胞黏附分子(EpCAM)的多模态成像探针。
Talanta. 2022 Dec 1;250:123715. doi: 10.1016/j.talanta.2022.123715. Epub 2022 Jul 9.
4
Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.用于体内非侵入性检测人类肝细胞癌的Glypican-3结合肽的鉴定
Macromol Biosci. 2017 Apr;17(4). doi: 10.1002/mabi.201600335. Epub 2016 Nov 15.
5
Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy.SP94 肽作为肝细胞癌成像和治疗的特异性探针的研究。
Sci Rep. 2016 Sep 21;6:33511. doi: 10.1038/srep33511.
6
Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors.间充质上皮转化因子(MET)的光学成像用于增强原发性和转移性肝肿瘤的检测与特征分析
Theranostics. 2016 Sep 9;6(12):2028-2038. doi: 10.7150/thno.15718. eCollection 2016.
7
An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis.一种新型肽,对 GPC3 具有高亲和力,可用于肝细胞癌诊断。
Biomater Sci. 2018 Dec 18;7(1):159-167. doi: 10.1039/c8bm01016a.
8
Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.开发一种 SPECT 示踪剂,用于成像非小细胞肺癌异种移植模型中的 c-Met 表达。
J Nucl Med. 2018 Nov;59(11):1686-1691. doi: 10.2967/jnumed.117.206730. Epub 2018 May 18.
9
Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.通过靶向c-Met依赖和非依赖途径的LZ-8预防肝细胞癌肿瘤进展的临床前试验。
PLoS One. 2015 Jan 21;10(1):e0114495. doi: 10.1371/journal.pone.0114495. eCollection 2015.
10
Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.中药配方七方化癥汤通过 HGF/c-Met 信号通路抑制肝癌转移。
Biomed Pharmacother. 2020 Dec;132:110867. doi: 10.1016/j.biopha.2020.110867. Epub 2020 Oct 16.

引用本文的文献

1
Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway.肽CCAT1-70aa通过MAPK/ERK途径促进肝细胞癌的增殖和侵袭。
Open Med (Wars). 2025 Aug 19;20(1):20251206. doi: 10.1515/med-2025-1206. eCollection 2025.
2
Opportunities and challenges of targeting c-Met in the treatment of digestive tumors.靶向c-Met在消化系统肿瘤治疗中的机遇与挑战
Front Oncol. 2022 Aug 1;12:923260. doi: 10.3389/fonc.2022.923260. eCollection 2022.